You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:
Firefox Internet Explorer 7 Safari (Mac and PC)
BrainStorm gets FDA fast-track status for ALS stem cell therapy Israel's BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a "fast-track" product for the treatment of amyotrophic lateral sclerosis (ALS).
Source: Reuters Posted on:
Tuesday, Oct 07, 2014, 8:15am Views: 1197